CHITOZAN HEALTH LLC

Summerville, SC · Founded 2018 · Materials · Private

Antimicrobial textiles and wound care products using patented silver chitosan technology

Claim this profile

Follows are private to you and power your alerts

Updated · chitozanhealth.com

Sector
Materials
Headquarters
Summerville, SC
Founded
2018
Latest Form D
$100K, Feb 2024
Total capital
$1.2M
Federal grants
$618K
3 awards · 2022–2023
Rank in peer group#80 of 90
Private capital raised
$606K
3 Form D · last Feb 2024
32 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

2021202220232024FEDERAL ↑EQUITY ↓Cumulative $1.2M$254K$309K$55K1st Form D$252K2nd Form D$254K3rd Form D$100K
2021202220232024FEDERAL ↑EQUITY ↓Cumulative $1.2M$254K$309K$55K1st Form D$252K2nd Form D$254K3rd Form D$100K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$100K
  • Federal grantHealth and Human S · Phase I · Investigation of chitosan-supported silver as a safe and effective broad-spectrum antimicrobial textile finish$55K
  • Private capital raisedForm D · SEC · 2nd filing$254K
  • Federal grantHealth and Human S · Phase I · Investigation of chitosan-supported silver as a safe and effective broad-spectrum antimicrobial textile finish$309K
  • Federal grantHealth and Human S · Phase I · Investigation of chitosan-supported silver as a safe and effective broad-spectrum antimicrobial textile finish$254K
  • Private capital raisedForm D · SEC · 1st filing$252K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 90 peers

Line = median

Materials · Material

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • John Stanley, Jr.Executive OfficerNamed in SEC Form D filings
  • Matthew TaylorExecutive OfficerNamed in SEC Form D filings
  • Dwight Van HornExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 6
  • PendingParticle Size Controlled Chitosan-silver Antimicrobial Solution And Method Of PreparationUSPTOApplication 18970796
  • PendingAntiviral And Antimicrobial Barrier CoatingsUSPTOApplication 18567181
  • PendingParticle Size Controlled Chitosan-silver Antimicrobial Solution And Method Of PreparationUSPTOApplication PCTUS2024060937
Show all 6 patent records
  • Particle Size Controlled Chitosan-silver Antimicrobial Solution And Method Of PreparationJun 26, 2025 · Application 18970796Pending
  • Antiviral And Antimicrobial Barrier CoatingsAug 8, 2024 · Application 18567181Pending
  • Particle Size Controlled Chitosan-silver Antimicrobial Solution And Method Of PreparationApplication PCTUS2024060937Pending
  • Particle Size Controlled Chitosan-silver Antimicrobial Solution And Method Of PreparationApplication 63613876Pending
  • Antiviral And Antimicrobial Barrier CoatingsApplication PCTUS2022032843Pending
  • Antiviral and Antimicrobial Barrier CoatingsApplication 63208815Pending

Regulatory activity · Materials

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .